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Although the role of miR-205 has been widely elucidated, the
function of its host gene (MIR205HG) is yet to be clarified. We have
recently investigated whether this gene is a simple endorsement
for miRNA production or it may act independently, demonstrating
its action as nuclear long noncoding RNA able to control basal-
luminal differentiation in the human prostate context, thus
deserving the reannotation as LEADR, Long Epithelial Alu-inter-
acting Differentiation-related RNA. Here, we describe the loss and
gain of function approaches experimentally used to modulate
LEADR expression, and the bioinformatic procedures employed to
analyze microarray data in our published article “LEADeR role of
miR-205 host gene as long noncoding RNA in prostate basal cell
differentiation” [1].
The high reproducibility of replicates, the strong concordance with
a validation technique, and the coherent behavior observed for
differentially expression features, both in terms of single genes and
deregulated pathways, not only support the quality of the data, but
also endorse their potential reuse. Very relevant are the diverse
silencing and overexpression strategies employed (all of which
analyzed in multiple biologically independent replicates), which
should allow other scientists to analyze our dataset for the specific
purpose of their research, may it be the study of MIR205HG
function as miRNA host gene, the investigation of its miRNA-
independent biological role or again the dissection of Aluces, University of Milan, Via Celoria 26, 20133, Milano, Italy.
andellini).
vier Inc. This is an open access article under the CC BY-NC-ND license (http://
S. Percio et al. / Data in brief 29 (2020) 1051392Specifications Table
Subject Biochemistry
Specific subject area Transcriptom














Parameters for data collection Prostate cells




Data source location Fondazione IR
Data accessibility Repository na
Data identific
Direct URL to







Value of the Data
 To our knowledge this dataset is the first-in-cla
MIR205HG and therefore it is a unique resourc
 Our dataset may be useful to all researchers in
explored field.
 The different silencing and overexpression strat
specific research purpose concerning the study
Alu contribution in the MIR205HG function.sequence involvement in the mechanism of action of long non-
coding RNAs, which is a hot topic in the field.
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1.1. Experimental plan
The precursor sequence of humanmiR-205 is located on the positive strand of the chr1q32 region
and spans the last intron/exon junction of a gene originally named as NPCA-5 (alias LOC642587).
Given that no protein product has been experimentally observed, this gene was re-named as miR-
205 Host Gene (MIR205HG) in the assumption that it merely hosts miR-205. Nonetheless, latest
researches have started to shed light on a possible regulatory role of MIR205HG as competing
endogenous RNA, spongingmiR-590 andmiR-122 in head and neck and cervical tumors respectively
[2,3].
In this regard, we have investigated, for the first time, the function ofMIR205HG in human prostate,
thus discovering that it is mostly expressed in the basal layer of epithelium, and progressively lost
during luminal differentiation and tumorigenesis [1]. MIR205HG processed transcripts behave as nu-
clear intergenic long noncoding RNAs (lincRNAs), able per se to regulate basal-luminal differentiation,
through the repression of the interferon pathway [1]. Mechanistically, we hypothesized that, by means
of an Alu-like element present in the second exon,MIR205HG directly binds to the promoter regions of
target genes, which are characterized themselves by an Alu element in proximity of an interferon-
regulatory factor (IRF) binding site. In addition, we experimentally observed that this lincRNA in-
teracts with IRF1 protein, thus modulating its occupancy on target genes. In line with this evidence, we
proposed MIR205HG as a buffer of IRF1 transcription factor activity [1].
Since MIR205HG operates autonomously from miR-205 and all its isoforms could be considered
functionally active due to the presence of the Alu element, we decided to re-annotate it as LEADR [1].
In Profumo, Forte, Percio, Rotundo et al. [1], our main goal was to discover LEADR biological role in
human prostate cells, and herewe describe, in detail, the employed experimental procedures. Basically,
we adopted gain and loss of function approaches to modify LEADR levels in different prostate cell lines
and analyzed the consequent gene expression changes. Aside the techniques used to modulate LEADR-
specific transcripts only, we also considered both the modification of its entire locus (including miR-
205) and the overexpression of transcripts deleted for functional elements (i.e. Alu) (Fig. 1).
Transcriptome changes were measured through hybridization on a microarray platform comparing
the different perturbations of LEADR expression operated in normal and tumor prostate cell lines
(RWPE-1 and DU145, respectively).
Gene expression profile analysis led us to unearth LEADR function in prostate cells and speculate
about the mechanism through which it regulates the transcription of its target genes. Asides this, our
experiments could have a value for potential reuse in taking researchers to the discovery of new
biological functions of LEADR. Therefore, the dataset described here paves the way for a better char-
acterization of LEADR gene and a clarification of its transcriptional/functional interplay with the hosted
miR-205.
1.2. Preprocessing pipeline and biological replicate management
Transcriptomic quantification from prostate cells modulated for LEADR expressionwas generated in
our laboratory as three independent microarray experiments. For each dataset, the same preprocessing
pipeline was applied (Fig. 2a), consisting of robust spline normalization (rsn) and filtering of low
quality data. As illustrated in the box plots (Fig. 2b), this method confers a more stable inference even if
the number of arrays is small, and it is able to remove any fluctuation due to systematic bias. Around
25% of probes in each microarray experiment showed sufficient quality to pass the threshold (Fig. 2a).
Several biological replicates for each modulation were introduced in the experimental design to
enhance the statistical power and improve robustness of the biological variability estimation in the
subsequent bioinformatic analyses. Specifically, all experiments were conducted as independent bio-
logical triplicates, except for the overexpression of LEADR RefSeq transcript and gene, which were
performed as quadruplicates.
Principal component analysis (PCA) was performed to evaluate the quality of biological replicates in
terms of explained variance. Upon plotting all samples in the space of principal components, a clear
Fig. 1. LEADR modulation pipeline. The scheme describes, from top to bottom, i) NCBI RefSeq of MIR205HG with indication of the
Alu element and pre-miR-205, ii) the constructs used for overexpression of whole MIR205HG gene, RefSeq, and Alu-deleted RefSeq
(DAlu) transcripts with indication of target sequences of gapmers and siRNA used for silencing, iii) the loss and gain of function
approaches with a summary of the effects induced by the different MIR205HG locus modulations, and iv) gene expression profile of
cells perturbed for MIR205HG expression achieved through hybridization on a microarray platform.
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distribution showed a good congruency among the biological replicates confirming data consistency
and reproducibility.
1.3. Evaluation of transfection efficacy
Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) was used to validate
LEADR silencing in RWPE-1 cells upon transfection with siRNA or gapmers (Fig. 3a).
Fig. 2. Preprocessing pipeline and sample consistency. Flow chart describes the pipeline applied to analyze gene expression
profiles. Raw data (total number of probes is indicated in brackets) obtained by the hybridization on Illumina HumanHT-12 v4 chips
were log2-transformed and normalized according to the rsn method. Probes with both at least one significant detection p-value
(threshold of 0.01) and an associated official gene symbol were considered. Among filtered probes, for those with the same gene
symbol, the probe with the highest variance was selected. For each of the three datasets, the final normalized matrix of expression
profile was obtained (the number of retained probes is indicated in brackets) and used for differential expression analysis (a). Box
plots for each GEO dataset with raw expression (top) and rsn normalized values (bottom), respectively (b). Scatter plot of sample
distribution in the space of principal components (PCs) for each GEO dataset. Replicates affected by the same modulation are
indicated with the same color (c).
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Fig. 3. Evaluation of transfection efficacy. Bar plots of qRT-PCR show the ability of both siLEADR and gapLEADR oligomers to
abrogate LEADR expression and of gapINT1 oligomer to inhibit both LEADR and miR-205. Mean þ s.d. (n ¼ 3 qRT-PCR measurements)
plotted (a). Full-size bright-field images show morphological changes occurring in DU145 cells transfected with empty vector (EV),
RefSeq, and gene vectors respectively. Scale bar, 50 mm (b). Bar plots of qRT-PCR show the efficacy in restoring the expression of
LEADR only or of LEADR and miR-205, upon transfection with RefSeq or gene vector, respectively. Mean þ s.d. (n ¼ 3 qRT-PCR
measurements) plotted (c). End point RT-PCR shows the efficient transfection and transcription of the vector carrying RefSeq
transcript depleted for a portion of the Alu element (DAlu). The product has an evidently lower molecular weight as compared to the
wild type (RefSeq) (d).
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formance in terms of silencing efficacy across biological replicates, though the reduction of LEADRwas
overall more pronounced with gapmers as compared to siRNA. Specifically, the gapmer designed to
target an intron within LEADR primary transcript (gapINT1) revealed to be able to reduce both LEADR
and miR-205 expression levels (Fig. 3a).
In addition, the efficacy of transfection with siRNA and gapmers in RWPE-1 cells was supported by
changes in morphology, as assessed through bright-field imaging in Profumo, Forte, Percio, Rotundo
et al. [1].
Morphological changes were appreciable also in DU145 cells transfected with either the entire
LEADR gene or the RefSeq transcript, as compared to cells transfected with the empty vector (EV)
(Fig. 3b). Consistent with this change, LEADR resulted to be overexpressed in both cases (Fig. 3c).
Notably, transfection of the entire locus was reflected by a higher level of both LEADR and miR-205,
while that of the RefSeq sequence showed an increase of LEADR only (Fig. 3c). Changes were consistent
across biological replicates.
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Alu element, LEADR expression levels increased more than ten times with respect to the control. This
result corroborates the efficacy of the transfection albeit LEADR transcript was deprived of the Alu
element, which is extremely important for its function as described in Profumo, Forte, Percio, Rotundo
et al. [1]. Moreover, end point RT-PCR of RNA extracted from DU145 cells transfected with either LEADR
RefSeq or correspondent Alu-deleted transcript showed amplicons of different molecular weight,
confirming transcription of a shorter LEADR sequence in DAlu-cells (Fig. 3d).
1.4. Bioinformatic analyses
Transcriptomic changes arising from LEADR modulation were analyzed to infer LEADR function in
prostate cells. We expected to observe an opposite trend according to the alterations induced in the
two different cell lines (silencing vs. overexpression). Prevalently, LEADR revealed to have a repressive
attitude since most of the genes were up-regulated upon its silencing (Fig. 4a). In line with this evi-
dence, the up-regulated genes showed more overlap in all the three silencing experiments than the
down-regulated ones, as reported in the Venn diagrams (Fig. 4a).
As a complementary approach, we ectopically expressed the RefSeq or gene sequences in
DU145 cells and observed a high overlap in terms of both up- and down-regulated genes (Fig. 4b).
Moreover, we wondered whether the genes overlapping across silencing experiments showed an
opposite trend upon LEADR overexpression. This resulted to be the case, as major overlap was observed
between genes up-regulated upon silencing and those down-regulated upon overexpression, as clearly
illustrated in Profumo, Forte, Percio, Rotundo et al. [1]. Such evidence prompted us to focus on these
genes as bona fide LEADR direct targets [1].
In order to corroborate our hypothesis, we applied a holist approach evaluating the concordance in
terms of pathwaymodulation on genes commonly up-regulated upon silencing (65 genes according to
the Venn diagram in Fig. 4a, right) and genes commonly down-regulated upon overexpression (97
genes according to the Venn diagram in Fig. 4b, left). On these selections, we performed an over-
representation analysis investigating a possible enrichment of general molecular mechanisms
belonging to the Hallmark collection of the MSigDB database [4]. Interestingly, we observed a high
overlap among gene sets: the two lists of hallmarks shared seven pathways, though different for rank
and size, with interferon pathways at the top of both rankings (Fig. 4c).
Overall, bioinformatic analyses revealed a strong concordance among LEADR modulations and a
good coherence (albeit the sign of expression) between LEADR silencing and overexpression, thus
highlighting the efficacy and the correctness of the experimental procedure.
1.5. Technical validation of microarray measurement
To confirm the validity of high-throughput microarray measures, we randomly selected 28 genes
commonly modulated across LEADR silencing experiments in RWPE-1 cells, and we evaluated their
expression levels using an independent technique, namely TaqMan-based qRT-PCR, in RWPE-1 cells
transfected with gapLEADR and gapCTR. Plotting fold change (FC) values of both qRT-PCR and
microarray analyses, a strong linear relationship clearly emerged (Fig. 4d), suggesting a considerable
concordance in terms of trend and magnitude. Overall, this observation corroborates the quality and
the informativeness of our high-throughput data, thus stimulating their potential reuse by other au-
thors for the discovery of new LEADR functions.
1.6. Data records
Raw and normalized gene expression data in the study have been deposited at Gene Expression
Omnibus as a superseries with the accession number GSE104003. This superseries is composed of
three different datasets (GEO103654, GEO103655, and GEO103656), each one including LEADR mod-
ulation experiments and relative controls, as previously described (Table 1).
Fig. 4. Differential expression upon LEADR modulations. Differential expression analysis between gapLEADR, siLEADR, and
gapINT1 and their respective controls (CTRs) was visualized in the volcano plots; blue dots represent down-regulated genes while
red dots the up-regulated ones (top). Venn diagrams show the overlap among all three silencing methods in terms of down- and up-
regulated genes (bottom) (a). Differential expression analysis between gene, RefSeq, and DAlu, and their respective control (EV) was
visualized in the volcano plots; blue dots represent down-regulated genes while red dots the up-regulated ones (top). Venn dia-
grams show the overlap between gene and RefSeq overexpression methods in terms of down- and up-regulated genes (bottom) (b).
Bar plots of overrepresentation analysis performed on genes commonly down-regulated upon overexpression (97 according to the
left Venn diagram of Figure 4b), and those commonly up-regulated upon silencing (65 genes according to the right Venn diagram of
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2.1. LEADR modulation
We silenced LEADR in RWPE-1 cell line, a human normal prostate model, where it is endogenously
expressed at high levels. To solely abrogate LEADR expression, a single-stranded LNA/DNA/LNA anti-
sense gapmer (gapLEADR) or a conventional small interfering RNA (siLEADR), both complementary to
an exon/exon junction in RefSeq sequence, were employed (Fig. 1). Gapmer nuclear translocation and
RNAse H-mediated cleavage prompted us to adopt this approach to improve the efficacy of silencing in
this compartment, which we and others demonstrated to be the main LEADR subcellular localization
[1,2]. Another gapmer (gapINT1) was designed to target an intron within LEADR primary transcript
(Fig. 1), and we showed that it was able to reduce the expression of both LEADR and miR-205 [1]. This
strategy was employed to study a possible transcriptional and functional relationship between LEADR
and its hosted miRNA. In addition, a control siRNA (siCTR) and gapmer (gapCTR) with no homology to
any known human mRNA were used for comparative analyses.
We reconstituted LEADR expression by stably transfecting plasmid vectors containing either the full
length (hereafter gene) or the RefSeq transcript sequences in DU145 cell line (Fig. 1), a human prostate
cancer model, where both LEADR and miR-205 are normally not expressed.
In addition, in the same cell line, a vector containing the RefSeq sequence deleted for a portion of the
Alu element (DAlu) was introduced to study the impact of this depletion on LEADR regulatory functions
(Fig. 1). An empty vector was included in all experiments as control (EV).
2.2. RNA isolation and microarray hybridization
Total RNA was isolated from stable clones of DU145 overexpressing LEADR transcripts (gene,
RefSeq or DAlu) or from RWPE-1 cells transiently silenced for LEADR expression (gapLEADR,
siLEADR or gapINT1) 72 hours upon transfection. RNA was extracted with Qiazol reagent and pu-
rified with QIAGEN RNeasy mini kit (QIAGEN, Hilden, Germany) in accordance with the prescribed
protocol. DNase I treatment was performed, and the quality of extracted RNA was evaluated
through Agilent Bioanalyzer. Eight hundred ng of total RNA was reverse transcribed, labelled with
biotin, and amplified overnight using the Illumina RNA TotalPrep Amplification kit (Thermo Fisher)
according to manufacturer's protocol. One mg of the biotinylated cRNA was mixed with the Hyb E1
hybridization buffer and hybridized to the Illumina HumanHT-12 v4 chips (47,323 probes) at 58 C
overnight. Array chips were washed with manufacturer's E1BC solution, stained with 1 mg/mL Cy3-
streptavidine, and scanned with the Illumina BeadArray Reader according to the standard Illumina
protocols.
2.3. Preprocessing methods
Raw data were log2-transformed and normalized by using the rsn method implemented in the lumi
package to deal with intensity-dependent and spatial bias [5]. Furthermore, normalized data were
filtered by retaining probes with both at least one detection p-value < 0.01 across samples and an
associated official gene symbol. For probesmapping on the same gene symbol, the onewith the highest
variance was selected.
2.4. Differential expression analyses
Differential expression was measured in terms of fold change (FC) using the limma package of R
environment [6]. In general, significancewas assessed in terms of False Discovery Rate (FDR) tomanageFigure 4a). Hallmark collection of MSigDB database is sorted according to the FDR associated to the enrichment score (c). Scatter plot
showing the linear trend between fold-changes of selected genes upon gapLEADR silencing, as measured by microarray platform
and qRT-PCR as technical validation. Equation of linear regression as well as r-squared (R2) are plotted (d).
Table 1
GEO repository. Description of the three deposited datasets; the cell line (Source), the type of modulation (Protocol 1), the
sample manipulation (Protocol 2), the hybridization (Protocol 3), the description of the sample (Samples), and the correspondent
GEO accession number (Data) are indicated. Different colors are used to distinguish the three different datasets.
Source Protocol 1 Protocol 2 Protocol 3 Samples Data 
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S. Percio et al. / Data in brief 29 (2020) 105139 11multiple test comparisons (threshold of 0.05). However, only few genes resulted significantly differ-
entially expressed in terms of FDR correction in overexpression experiments. In this regard, such ex-
periments have an intrinsic higher variability due to biological and technical causes. For example, since
the DU145 cell line model does not constitutively express basal features, the sole reconstitution of
LEADR could not be sufficient to induce the acquisition of a frankly basal phenotype, thus resulting in a
hybrid state with marginal gene expression changes. Moreover, transfected cells have had the possi-
bility to settle into plasmid integration for a long time, and they might have therefore adapted to this
condition (in our case, we collected transcriptomic profile of stable clones of DU145 cells, while for
silencing experiments performed in RWPE-1 cells we evaluated gene expression acutely 3 days after
transfection). In this regard, we reasoned that FDR is a too restrictive correction for overexpression
experiments, and we considered as significantly differentially expressed all genes with at least a
nominal p-value < 0.05.
The overrepresentation analysis was conducted retaining only the significant enrichment scores
(FDR threshold of 0.05).
2.5. Analysis of qRT-PCR data
In TaqMan-based qRT-PCR, we calculated FCs as 2-DDCt and averaged them among biological rep-
licates. Specifically, for each i-measurement, FC values were estimated as the differential expression
between gapLEADR and gapCTR, considering GAPDH as endogenous control as follows:
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